Use of Levonorgestrel Intrauterine System for Medical Indications in Adolescents

Bayer LL, Lisa L. Bayer, Hillard PJ, Paula J. Adams Hillard
The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2013 · vol. 52(4) , pp. S54–S58 · doi:10.1016/j.jadohealth.2012.09.022 · PMID:23535058 · W1979627476
review OA: closed CC0 ⤵ 11 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This paper reviews the use of the levonorgestrel intrauterine system for medical indications in adolescent patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The levonorgestrel intrauterine system (LNG-IUS) is an underused contraceptive method in adolescent populations. In addition to being a highly effective, reversible, long-acting contraception, the LNG-IUS has many noncontraceptive health benefits including reduced menstrual bleeding, decreased dysmenorrhea and pelvic pain related to endometriosis, and menstruation suppression in teens with physical or developmental disabilities. The LNG-IUS can also provide endometrial protection in teens with chronic anovulation, and may be used to treat endometrial hyperplasia and cancer. This review examines the evidence supporting the use of the LNG-IUS in adolescents for these noncontraceptive benefits.

My notes (saved in your browser only)

MeSH descriptors

Contraceptives, Oral, Synthetic Intrauterine Devices, Medicated Levonorgestrel Adolescent Contraceptives, Oral, Synthetic Female Genital Diseases, Female Genital Diseases, Female Humans Levonorgestrel Menstruation Disturbances Menstruation Disturbances

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (86)

Cited by (12)

Source provenance

europepmc
last seen: 2026-08-18T06:10:16.649438+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:19:05.543671+00:00
License: CC0 · commercial use OK